Search Results - "THIBERT, RONALD L"
-
1
Early and effective treatment of KCNQ2 encephalopathy
Published in Epilepsia (Copenhagen) (01-05-2015)“…Summary Objectives To describe the antiepileptic drug (AED) treatment of patients with early infantile epileptic encephalopathy due to KCNQ2 mutations during…”
Get full text
Journal Article -
2
A Quantitative Electrophysiological Biomarker of Duplication 15q11.2-q13.1 Syndrome
Published in PloS one (15-12-2016)“…Duplications of 15q11.2-q13.1 (Dup15q syndrome) are highly penetrant for autism spectrum disorder (ASD). A distinct electrophysiological (EEG) pattern…”
Get full text
Journal Article -
3
Angelman syndrome in adolescence and adulthood: A retrospective chart review of 53 cases
Published in American journal of medical genetics. Part A (01-06-2018)“…Angelman syndrome is a neurogenetic disorder with varying clinical presentations and symptoms as the individual ages. The goal of this study was to…”
Get full text
Journal Article -
4
Neurologic Manifestations of Angelman Syndrome
Published in Pediatric neurology (01-04-2013)“…Abstract Angelman syndrome is a neurogenetic disorder characterized by the loss or reduction of the ubiquitin-protein ligase E3A enzyme. Angelman syndrome…”
Get full text
Journal Article -
5
Delta rhythmicity is a reliable EEG biomarker in Angelman syndrome: a parallel mouse and human analysis
Published in Journal of neurodevelopmental disorders (08-05-2017)“…Clinicians have qualitatively described rhythmic delta activity as a prominent EEG abnormality in individuals with Angelman syndrome, but this phenotype has…”
Get full text
Journal Article -
6
The Interstitial Duplication 15q11.2-q13 Syndrome Includes Autism, Mild Facial Anomalies and a Characteristic EEG Signature
Published in Autism research (01-08-2013)“…Chromosomal copy number variants (CNV) are the most common genetic lesion found in autism. Many autism‐associated CNVs are duplications of chromosome 15q…”
Get full text
Journal Article -
7
Angelman syndrome in adulthood
Published in American journal of medical genetics. Part A (01-02-2015)“…Angelman syndrome (AS) is a neurogenetic disorder. The goal of this study was to investigate the primary health issues affecting adults with AS and to further…”
Get full text
Journal Article -
8
A survey of seizures and current treatments in 15q duplication syndrome
Published in Epilepsia (Copenhagen) (01-03-2014)“…Summary Objective Seizures are common in individuals with duplications of chromosome 15q11.2‐q13 (Dup15q). The goal of this study was to examine the phenotypes…”
Get full text
Journal Article -
9
Understanding relationships between autism, intelligence, and epilepsy: a cross‐disorder approach
Published in Developmental medicine and child neurology (01-02-2013)“…Aim As relationships between autistic traits, epilepsy, and cognitive functioning remain poorly understood, these associations were explored in the…”
Get full text
Journal Article -
10
Epilepsy in Angelman syndrome: A questionnaire‐based assessment of the natural history and current treatment options
Published in Epilepsia (Copenhagen) (01-11-2009)“…Summary Purpose: Angelman syndrome (AS) commonly presents with epilepsy (>80%). The goal of this study was to examine the natural history and various…”
Get full text
Journal Article -
11
Hippocampal Abnormalities in Magnetic Resonance Imaging (MRI) of 15q Duplication Syndromes
Published in Journal of child neurology (01-03-2015)“…Patients with 15q duplication syndromes, including isodicentric chromosome 15 and interstitial duplications, usually present with autism spectrum disorder,…”
Get full text
Journal Article -
12
The Use of Magnetic Resonance Spectroscopy in the Evaluation of Pediatric Patients With Seizures
Published in Pediatric neurology (01-05-2016)“…Abstract Background The objective was to determine if it is useful to routinely add magnetic resonance spectroscopy (MRS) to magnetic resonance imaging (MRI)…”
Get full text
Journal Article -
13
Erratum to: Delta rhythmicity is a reliable EEG biomarker in Angelman syndrome: a parallel mouse and human analysis
Published in Journal of neurodevelopmental disorders (17-07-2017)“…[This corrects the article DOI: 10.1186/s11689-017-9195-8.]…”
Get full text
Journal Article -
14
Angelman syndrome genotypes manifest varying degrees of clinical severity and developmental impairment
Published in Molecular psychiatry (01-07-2021)“…Angelman Syndrome (AS) is a severe neurodevelopmental disorder due to impaired expression of UBE3A in neurons. There are several genetic mechanisms that impair…”
Get full text
Journal Article -
15
Teaching NeuroImage: Notched Delta and Angelman Syndrome
Published in Neurology (12-10-2021)Get full text
Journal Article -
16
Tolerability and dosing experience of intravenous levetiracetam in children and infants
Published in Epilepsy research (01-10-2008)“…Summary Objective To evaluate the use and tolerability of intravenous (IV) levetiracetam (LEV) in a pediatric cohort under 14 years of age. Methods A…”
Get full text
Journal Article -
17
Reversible uncal herniation in a neonate with a large MCA infarct
Published in Brain & development (Tokyo. 1979) (01-11-2009)“…Abstract Uncal herniation due to a large cerebral infarct is well-described in adults, with high rates of morbidity and mortality. This phenomenon, however,…”
Get full text
Journal Article -
18
Seizure treatment in Angelman syndrome: A case series from the Angelman Syndrome Clinic at Massachusetts General Hospital
Published in Epilepsy & behavior (01-07-2016)“…Abstract Epilepsy is a common feature of Angelman syndrome (~ 80–90%), with the most common seizure types including myoclonic, atonic, atypical absence, focal,…”
Get full text
Journal Article -
19
If not Angelman, what is it? a review of Angelman-like syndromes
Published in American journal of medical genetics. Part A (01-04-2014)“…Angelman syndrome (AS) is caused by a lack of expression of the maternally inherited UBE3A gene in the brain. However, about 10% of individuals with a clinical…”
Get full text
Journal Article -
20
The STARS Phase 2 Study: A Randomized Controlled Trial of Gaboxadol in Angelman Syndrome
Published in Neurology (16-02-2021)“…To evaluate safety and tolerability and exploratory efficacy end points for gaboxadol (OV101) compared with placebo in individuals with Angelman syndrome (AS)…”
Get full text
Journal Article